Mechanisms of asthma and allergic inflammationTGF-β differentially regulates TH2 cytokine-induced eotaxin and eotaxin-3 release by human airway smooth muscle cells
Section snippets
HASM culture
HASMs from 2 donors were purchased from Stratagene (La Jolla, Calif). Cells were characterized and stained positive for α-smooth muscle actin. Cells were cultured in Dulbecco modified Eagle medium/nutrient mixture F12 (1:1; Invitrogen, Carlsbad, Calif) containing 25 mmol/L HEPES (Invitrogen), 10% (vol/vol) FCS (Invitrogen) supplemented with 2.5 mmol/L l-glutamine (Cambrex, East Rutherford, NJ), 1% (vol/vol) nonessential amino acids (Invitrogen), 50 U/mL penicillin, and 50 μg/mL streptomycin
Cytokine-induced eotaxin and eotaxin-3 release
To study the effect of TH2 cytokines on the release of eotaxins by HASMs, serum-starved confluent monolayers were incubated with IL-4, IL-13, and IL-9 in serum-free medium. The TH2 cytokines IL-4 and IL-13 induced eotaxin and eotaxin-3 release by HASMs in a dose-dependent manner (Fig 1, A and B). IL-4 induced eotaxin release at low concentrations, whereas IL-13 was less potent in inducing eotaxin release. Eotaxin-3 release, however, was induced at low concentrations of both IL-4 and IL-13.
Discussion
In this study we have shown that HASMs produce eotaxin and eotaxin-3 upon stimulation with the TH2 cytokines IL-4 and IL-13. HASMs did not release eotaxin-2 protein upon stimulation with the TH2 cytokines IL-4 and IL-13. A low concentration (0.5 ng/mL) of TGF-β increased IL-4–induced and IL-13–induced eotaxin release, whereas it decreased the release of eotaxin-3. At the same concentration, TGF-β alone altered neither eotaxin nor eotaxin-3 release.
We have shown for the first time that IL-4 and
References (44)
Is TGF-beta1 the key to suppression of human asthma?
Trends Immunol
(2001)- et al.
Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids
Cytokine
(2002) - et al.
Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine
Genomics
(1997) - et al.
Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo
Blood
(2002) - et al.
Molecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cells
Blood
(2001) - et al.
Characterization of the CC chemokine receptor 3 on human keratinocytes
J Invest Dermatol
(2001) - et al.
Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3
J Biol Chem
(1999) - et al.
Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils
J Invest Dermatol
(2001) - et al.
Regulatory T cells control the development of allergic disease and asthma
J Allergy Clin Immunol
(2003) - et al.
Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells
Am J Respir Crit Care Med
(1999)
Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids
Br J Pharmacol
Eotaxins. Contributing to the diversity of eosinophil recruitment and activation
Am J Respir Cell Mol Biol
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation
J Exp Med
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes
J Exp Med
A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils
J Immunol
Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation
Clin Exp Immunol
C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES)
J Immunol
Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge
Am J Respir Cell Mol Biol
Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues
Am J Respir Cell Mol Biol
Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
Am J Respir Cell Mol Biol
IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy
J Immunol
Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells
Clin Exp Allergy
Cited by (36)
The Role of Th17/IL-17 on Eosinophilic Inflammation
2013, Journal of AutoimmunityEosinophil Trafficking
2013, Eosinophils in Health and DiseaseEosinophil Trafficking
2012, Eosinophils in Health and DiseaseFibroblast phenotypes and their activity are changed in the wound healing process after lung transplantation
2011, Journal of Heart and Lung TransplantationRole of TGF-β in tissue eosinophilia associated with vernal keratoconjunctivitis
2010, Experimental Eye ResearchCitation Excerpt :There have been no previous reports about the effect of TGF-β1 on the production of eotaxin by conjunctival and corneal fibroblasts. Recently, Wenzel et al. (2002) and Zuyderduyn et al. (2004) revealed that TGF-β1 and IL-4/IL-13 synergistically increase eotaxin expression by human airway fibroblasts and smooth muscle cells. Eotaxin is a C–C chemokine with a strong direct chemoattractant effect on eosinophils.
Expression of IL-4 receptor α on smooth muscle cells is not necessary for development of experimental allergic asthma
2010, Journal of Allergy and Clinical Immunology
Funded by The Netherlands Asthma Foundation (grant 00.17) and AstraZeneca (Lund, Sweden).